Genetic basis of progressive familial intrahepatic cholestasis

Journal of Hepatology

Volumn 31, Issue 2, 1999, Pages 377-381

  Jacquemin, Emmanuel ^a   Hadchouel, Michelle ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

BILE ACID BLOOD LEVEL; CHOLESTASIS; FAMILIAL DISEASE; GENE MUTATION; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0032806949     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80240-2     Document Type: Review

References (42)

1. Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. J Pediatr. 67:1965;1025-1028.
2. Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child. 117:1969;112-124.
3. Linarelli LG, Williams CN, Phillips MJ. Byler's disease: fatal intrahepatic cholestasis. J Pediatr. 81:1972;484-492.
4. Williams CN, Kaye R, Baker L, et al. Progressive familial cholestatic cirrhosis and bile acid metabolism. J Pediatr. 81:1972;493-500.
5. Maggiore G, Bernard O, Riely C, et al. Normal serum gammaglutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr. 111:1987;251-252.
6. Whitington PF, Freese DK, Alonso EM, et al. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 18:1994;134-141.
7. Tazawa Y, Yamada M, Nakagawa M, et al. Bile acids profiles in siblings with progressive intrahepatic cholestasis: absence of biliary chenodeoxycholate. J Pediatr Gastroenterol Nutr. 4:1985;32-37.
8. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M, et al. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur J Pediatr. 153:1994;424-428.
9. 27-steroid dehydrogenase/isomerase deficiency. J Pediatr. 125:1994;379-384.
10. 4-3 oxosteroid 5β-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest. 82:1988;2148-2157.
11. Carlton VEH, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet. 4:1995;1049-1053.
12. Houwen RHJ, Baharloo S, Blankenship K, et al. Genome screening by searching for shared fragments: mapping of a gene for benign recurrent intrahepatic cholestasis. Nat Genet. 8:1994;380-386.
13. Strautnieks SS, Kagalwalla AF, Tanner MS, Knisely AS, Bull L, Freimer N, et al. Identification of a locus for progressive familial intrahepatic cholestasis (PFIC2) on chromosome 2q24. Am J Hum Genet. 61:1997;630-633.
14. Bull LN, van Eijk MJT, Pawlikowska L, de Young JA, Juiun J, Liao M, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet. 18:1998;219-224.
15. de Vree JML, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA. 95:1998;282-287.
16. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 20:1998;233-238.
17. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med. 339:1998;1217-1227.
18. Bull LN, Carlton VEH, Stricker NL, Baharloo S, de Young JA, Freimer N, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology. 26:1997;155-164.
19. Alonso EM, Snover DC, Montag A, et al. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 18:1994;128-133.
20. Winklhofer-Roob BM, Shmerling DH, Soler R, et al. Progressive idiopathic cholestasis presenting with profuse watery diarrhea and recurrent infections (Byler's disease). Acta Pediatr. 81:1992;637-640.
21. Bourke B, Goggin N, Walsh D, Kennedy S, Setchell KDR, Drumm B, et al. Byler-like familial cholestasis in an extended kindred. Arch Dis Child. 75:1996;223-227.
22. Mutero A, Bull LN, Pawlikowska L, Freimer N, Scharschmidt BF, Lomri N, et al. Cloning and tissue distribution of the rat homologue of the human gene involved in familial intrahepatic cholestasis type 1. [abstract] Hepatology. 28:1998;530A.
23. Naveh Y, Bassan L, Rosenthal E, Berkowitz D, Jaffe M, Mandel H, et al. Progressive intrahepatic cholestasis among the Arab population of Israel. J Pediatr Gastroenterol Nutr. 24:1997;548-554.
24. Arnell A, Nemeth A, Anneren G, et al. Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-22. Hum Genet. 100:1997;378-381.
25. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem. 273:1998;10046-10050.
26. Jansen P, Hooiveld G, Jacquemin E, Sokal E, van Goor H, Koning J, et al. The canalicular bile salt exporting protein BSEP is not expressed in patients with progressive familial intrahepatic cholestasis type 2. [abstract] Hepatology. 28:1998;498A.
27. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology. 23:1996;904-908.
28. Maggiore G, Bernard O, Hadchouel M, et al. Diagnostic value of serum γ-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr. 12:1991;21-26.
29. Smit JJM, Shinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:1993;451-462.
30. Smith AJ, Timmermans-Herheijgers JLPM, Roelofsen B, Wirtz KWA, Blitterswijk WJ, Smit JJM, et al. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354:1994;263-266.
31. Reutz S, Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell. 77:1994;1071-1081.
32. Smit JJM, Shinkel AH, Mol CAAM, Majoor D, Mooi WJ, Jongsma APM, et al. Tissue distribution of the human MDR3 P-glycoprotein. Lab Invest. 71:1994;638-649.
33. Smith AJ, de Vree JML, Ottenhoff R, Oude Elferink RPJ, Schinkel AH, Borst P, et al. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidycholine excretion absent in mdr2 (-/-) mice. Hepatology. 28:1998;530-536.
34. Lincke CR, Smit JJM, van Der Velde-Koerts T, et al. Structure of the human MDR3 gene and physical mapping of the human MDR locus. J Biol Chem. 266:1991;5303-5310.
35. Jacquemin E, de Vree JML, Cresteil D, Dumont M, Bernard O, Hadchouel M, et al. MDR3 deficiency: progressive familial intrahepatic cholestasis (PFIC) due to MDR3 gene mutations. [abstract] Hepatology. 28:1998;316A.
36. van Nieuwkerk CJM, Oude Elferink RPJ, Groen AK, Ottenhoff R, Tytgat GNJ, Dingemans KP, et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 p-glycoprotein gene. Gastroenterology. 111:1996;165-171.
37. Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous nonsense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet. 353:1999;210-211.
38. Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 25:1997;519-523.
39. Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology. 95:1988;130-136.
40. Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). J Pediatr Surg. 30:1995;1635-1641.
41. Soubrane O, Gauthier F, Devictor D, Bernard O, Valayer J, Houssin D, et al. Orthotopic liver transplantation for Byler disease. Transplantation. 50:1990;804-806.
42. de Vree JML, Ottenhoff R, Smith AJ, Aten J, Groen AK, Oude Elferink RPJ, et al. Rapid correction of mdr2 deficiency by transplantation of MDR3 transgenic hepatocytes. [abstract] Hepatology. 28:1998;387A.